Replies to post #183974 on Bioelectronics Corp (BIEL)

[Steve43]

When a Company goes Global its intent is to go big. NHS approval was a shout out to Big Pharma about our potential. FDA clearance of two products set off the alarms that we were here, and produced a visit and inquiry by Bayer who came and performed an autopsy on our products and Management. That visit resulted in a redesign of one of our cleared products which has been MIA for a year. Bayer came and left, with others following in their path. We have been running in circles for over two years, while our products have been sitting in the richest most health conscious Market in the World. That seems to be a hell of a way to stay small. We are no secret to Big Pharma and never have been, they just sit by and watch our failed strategy play out. Time is ticking away, yes precious time is ticking away adding to the wasted two and half years of silence. JMHO Have a great morning.

[Simpsonly]

Couldn't agree more PT.
Two things that did it for me - expired CE Mark caused the laughably absurd 7 pallet $531K "deferred sale" to the EU. "Deferred sale"? How insane! Get the product out the door, get paid and get ready of re-order. That's how that works!

Second was the smelly mundipharma deal, with many hundreds of thousands in up-front Distributor Fees and Australia needs the CE to do it's own Regs, otherwise it's like dealing with the FDA. Mundi has been demanding its $$$ back and BIEL has not shipped one order to Oz other than a few samples long ago. Money's gone and mundi's screaming pi$$ed.

As said, if the CEO is not an inept, over the hill, bungler, the stock price will rise with sales, if he needs to retire now, it will stay in the toilet. Simple.